Life Science Industry

The life science industry continues to grow amid pricing pressures, new technologies, and new regulations. The changing landscape demands continued education in medical devices, pharmaceuticals, and biotechnologies.

Life Science Conferences

Life Science Advertising and Promotion Regulatory Affairs Conference

Reducing Risks & Increasing Effectiveness of Advertising & Promotion through Advertising & Promotion Regulatory Oversight, Interpreting & Implementing FDA Guidance on Medical Product Communications That Are Consistent With the FDA-Required Labeling and Guidance on Drug & Device Manufacturer Communications With Payors, Formulary Committees & Similar Entities
July 23-24, 2019 | Alexandria, VA | Hilton Alexandria Old Town

8th Annual Life Science Strengthening Patient Advocacy Engagement Conference

Enhancing Patient Advocacy Initiatives through an Increased Focus on Diverse Patient Populations and Comprehensive Alliance Building Efforts While Strategizing for Innovative and Improved Access Opportunities, Optimizing Data Circulation and Partnering for Patient Success
July 30-31, 2019 | Philadelphia, PA | Four Points by Sheraton Philadelphia City Center

Life Science Manufacturing Automation Optimization Conference

Ensuring Robust, Uninterrupted and Compliant Product Supply Chains through Facility Retrofitting to Integrate Industry 4.0 Capabilities and Connected Software Systems, Embracing IoT, and the Utilization of Cutting Edge Instrumentation
September 24-25, 2019 | Charlotte, NC

Regulatory Information Management Systems Conference

Establishing a Single Authoritative Source of Information, Global Harmonization & Tracking of Regulatory Documentation, Opportunities for Improving Quality & Usability of Regulatory Data, Integration of Multiple Regulatory Technologies into an Aligned System
January, 2020 | Arlington, VA

Latest News from our Life Science Blog

Collaborating with Key Thought Leaders

Erica Wertz from Alimera Sciences is presenting at 6th Annual Customer Centric Medical Information Conference. Preview her session, “Collaborating with Key Thought Leaders to Enhance MI Communications,” below.   Can you please give a brief description of your job...

FDA Guidance’s Impact on Ad & Promo

Glenn Byrd, an expert in strategic promotional regulatory affairs, is one of many professionals presenting at this year’s Life Science Advertising & Promotions Regulatory Affairs Conference. Preview some of the many topics featured at this year’s event below....

Methods for Quantifying Results in Patient Advocacy

Michael Bodulow, Senior Specialist, Patient Advocacy at Biomarin Pharmaceutical Inc., and Tara Herington, Vice President at Cardinal Health Sonexus™, are presenting at Q1’s 8th Annual Strengthening Patient Advocacy Engagement Conference this July.

2019 Medical Device and Diagnostic Industry Trends

View the full 2019 Industry Trends report to hear from industry peers on how organizations are adapting to prepare for continued growth and development.

Enhancing Medical Communication Deliverables

Elizabeth Pham, PhD, and Dannis Chang, PharmD, of Halozyme are presenting the session “Leverage Technology and Innovative Tools to Enhance Publication and Medical Communication Deliverables” at Q1’s 8th Annual Medical Communications & Dissemination of Scientific Information Conference.

Hitting Submission Timelines

Craig Gassman of Vericel Corporation is one of many experts featured at Q1 Productions’ 8th Annual Regulatory Operations & Submissions Conference in Philadelphia this June.

Building a Compliance Training Program

This year Q1’s Life Science Ethics & Compliance Training Conference is taking place in June in Chicago. Join us to hear from industry experts, including Daniel Simon from STERIS Corporation.

Data Integrity for Automation Engineers

Frederick Johnson of Genentech, Inc. is one of many experts presenting at Q1’s Life Sciences Manufacturing Automation Optimization Conference this April.

Mapping KOL Relationships

Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference taking place on April 29-30 features a mix of industry perspectives from experts, including Daniel Snyder of Revance Therapeutics, Inc.

FDA Regulatory Issues and Solutions

Jeff Gibbs from Hyman, Phelps & McNamara will be participating in the panel “Optimizing Primary Mode of Action Determination & Process to Appeal FDA Decisions” at Q1’s Combination Product Regulation Conference. See what he has to say on FDA regulatory issues below!

CONTACT US
Q1 Productions
500 N. Dearborn Suite 500
Chicago, IL 60654
T: 312.822.8100
F: 312.873.3969
marketing@q1productions.com

 

Share This